Atlas Trials

Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV

Clinical trial NCT00006145 · COMPLETED

Trial details

NCT number
NCT00006145
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Cytomegalovirus InfectionsHIV Infections
Start date
2000-08-01
Enrollment
350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.